Summary
- Chinook Investment Partners completed a growth investment in PractiVet
- PractiVet supplies veterinary infusion pumps and IV consumables nationwide
- Company says more than 30,000 infusion devices are deployed across veterinary settings
- Investment aimed at accelerating product innovation and market expansion
- Financial terms of the transaction were not disclosed
Colorado-based Chinook Investment Partners announced it has completed a growth investment in PractiVet, a provider of veterinary infusion devices, syringe pumps, and IV infusion consumables used in specialty, emergency, and academic veterinary practices.
Founded in 2007, PractiVet says its products are used by thousands of veterinary hospitals and universities nationwide, with more than 30,000 infusion devices currently deployed across clinical settings. The company focuses on infusion and critical care technologies designed to improve workflow efficiency, clinician safety, and patient care outcomes.
PractiVet will continue operating under its existing leadership and brand following the investment. The companies said the partnership is expected to support product development, strategic expansion, and additional investment opportunities within veterinary critical care and infusion therapy.
Chinook said the investment aligns with its broader strategy of supporting growth-focused businesses in the animal health sector. Terms of the transaction were not disclosed.
Information sourced from a Chinook Investment Partners press release.
